The market size of allergy diagnostic assay kits is projected to reach USD 8.02 billion by 2027, up from USD 3.53 billion in 2019, reflecting a Compound Annual Growth Rate (CAGR) of 10.8% during the forecast period. This growth is fueled by the increasing prevalence of rare allergies and the global burden of allergy-related diseases. Common allergies include drug, food, insect, latex, mold, pet, and pollen allergies, triggered when the immune system perceives certain substances, known as allergens, as harmful.
Allergies can be seasonal, year-round, or lifelong, and their rise is attributed to overly clean living conditions in developed countries, reducing exposure to immune-system-training germs. In contrast, developing and underdeveloped nations experience increased allergies due to unsanitary conditions and pollution.
Get a sample copy of the Allergy Diagnostic Assay Kits Market report: https://www.reportsanddata.com/download-free-sample/3583
Healthcare providers conduct skin and blood tests for early allergy detection, with the adoption of diagnostic kits expected to rise. The World Allergy Organization estimates a global allergy prevalence of 15-40% by 2030, contributing to the market’s revenue. Increased pollution, particularly in developing countries, is a significant cause of allergies, diagnosable through various tests, supporting market growth.
The World Health Organization predicts a global asthma patient count of 400 million by 2025, contributing to the escalating economic burden of allergies. Direct costs include healthcare and medication expenses, while indirect costs involve social support, work loss, and lower productivity. The growing global allergy disease burden will drive market trends.
In terms of applications, the food allergen assays segment, driven by FDA regulations on proper labeling and allergen testing, is expected to contribute significantly to market growth. Diagnostic laboratories, especially in underdeveloped and developing countries, are anticipated to dominate the end-use segment.
North America leads the market, fueled by major industry players, a prevalence of rare allergies, and environmental factors contributing to pollution. Key players in the market include Biomerieux, DST, Romer, Danaher, Siemens, EUROIMMUN, HYCOR, Omega Diagnostics, R-Biopharm AG, Lincoln Diagnostics, Thermo Fisher Scientific, Hob Biotech, Hycor Biomedical, and Stallergenes Greer.
The report also highlights notable developments such as SignalChem Biotech Inc.’s launch of COVID-19 ELISA kits in May 2020 and Romer Labs’ expansion of food allergen detection solutions in November 2019. Additionally, AESKU GROUP’s acquisition of Diagnostische Systeme & Technologien GmbH in April 2017 aimed to broaden its product portfolio to include allergy and food intolerance diagnostics.
The market study segments the global allergy diagnostic assay kits market based on product type, application, end-use, and region, covering allergen screening, allergen classification test, inhaled allergens assay, food allergens assay, drug allergens assay, and other allergens assay. The geographical breakdown includes North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.
Explore Trending Reports:
Request a customization of the report: https://www.reportsanddata.com/request-customization-form/3583
Thank you for reading our report. To know more about the customization or any query about the report contents, please connect with us and our team will ensure the report is tailored to meet your requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
Browse Latest Blogs: https://www.reportsanddata.com/blogs
Browse Latest Press Release: https://www.reportsanddata.com/press-release